{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreieuwb7wns3p6g2tbr7eiewx62lvic73cdkbgadbmu3qevbtlgxhpa",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mkj2mbuxv5v2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreig74o3bq4yp7xl226iv354agqy7nfowa5m44xfayu5bl4uaqfxlnq"
    },
    "mimeType": "image/jpeg",
    "size": 387087
  },
  "path": "/news/2026-04-tbi-survivors-psychedelics-symptom-relief.html",
  "publishedAt": "2026-04-27T16:00:02.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "A new study from the University of Victoria (UVic) has identified a segment of traumatic brain injury survivors who are using psychedelics to self-medicate for cognitive, mood and somatic symptoms such as headaches. In a first-of-its-kind study, clinical psychology researchers analyzed more than 6,100 responses collected from the global psychedelic survey. Researchers found that nearly 1,200 respondents reported using psychedelics to treat or manage a physical health condition.",
  "title": "TBI survivors turn to psychedelics for symptom relief"
}